BlueStone Venture Partners, LLC

BlueStone Venture Partners is a life sciences venture capital fund that capitalizes on the strength, creativity, and innovation found in entrepreneurial companies outside of the traditional investment hubs in the United States. Rooted in the Southwest, the firm focuses on its 'Core Four' verticals — Medical Devices, Diagnostics, Digital Health, and Life Science Research Tools — targeting companies primarily in the 'NATO states' (New Mexico, Arizona, Texas, and Oklahoma), regions historically overlooked by legacy venture capital despite strong universities, unique research centers, and significant infrastructure. The firm combines deep operational, technical, and financial expertise to create value for portfolio companies, leveraging strong external networks and relationships with industry-leading advisors and co-investors. BlueStone invests in early-stage companies from seed through Series B, with a typical check size ranging from $250K to $1M, and a fund size of approximately $50 million. As a return-driven fund, BlueStone will also invest in US-based companies outside the NATO states if they fit its investment criteria.